trial · primary record
NVG-291
Chronic Spinal Cord Injury
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 150 |
| Primary completion | 2027-12-14 |
| Primary endpoint | Efficacy of NVG-291 as measured by change from baseline in combined Graded and Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) Quantitative Prehension (QtP) score |
| Registry ID | NCT07799532 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:38.730Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07799532
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Nvg-291 · compound